Indium In-111 Pentetreotide and Moxetumomab Pasudotox-tdfk
Determining the interaction of Indium In-111 Pentetreotide and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indium pentetreotide in-111
Brand name: OctreoScan
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indium In-111 Pentetreotide-Moxetumomab pasudotox-tdfk Intravenous
- Indium In-111 Pentetreotide-Moxifloxacin
- Indium In-111 Pentetreotide-Moxifloxacin (Systemic)
- Indium In-111 Pentetreotide-Moxifloxacin Hydrochloride
- Indium In-111 Pentetreotide-Moxifloxacin Injection
- Indium In-111 Pentetreotide-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Indium Oxyquinoline
- Moxetumomab Pasudotox-tdfk-Indocid
- Moxetumomab Pasudotox-tdfk-Indocin
- Moxetumomab Pasudotox-tdfk-Indocin (Indomethacin Suppositories)
- Moxetumomab Pasudotox-tdfk-Indocin (Indomethacin Suspension)
- Moxetumomab Pasudotox-tdfk-Indocin Injection